ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Schmidt Of Germany UICC President Elect David Korn Appointed New Dean At Stanford

October 19, 1984

Carcinogenicity Test For Cis-Platinum Needed, DCT Says, But Declines To Pay For It

June 16, 1978

FDA Invites Ad Hoc Consumer Reps To ODAC Meetings

February 17, 1995

NCI, IOM Called To Congress to Explain Divergent Positions On Minority Research

January 29, 1999

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

May 29, 2009

Sausville to lead clinical research at Maryland.

December 5, 2003